DRREDDY vs INFY: Stock Comparison

Dr Reddys Laboratories Ltd vs Infosys LtdUpdated 12 August 2026, 4:08 PM ISTNSE & company filings

Infosys Ltd is the larger company by market capitalisation. Infosys Ltd shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

DRREDDY leads 1; INFY leads 12 of 13

Not a rating
These companies operate in different sectors (Healthcare vs Information Technology). Valuation and leverage norms differ across sectors, so cross-sector ratio comparisons can mislead — compare each against its own sector peers too.

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

DRREDDYINFY

Valuation lens

What price are you paying?

Market CapContext only
DRREDDY
₹1 L Cr
INFY
₹4.75 L Cr
P/E RatioINFY has the lower reading
DRREDDY
31.05x
INFY
15.84x
P/B RatioDRREDDY has the lower reading
DRREDDY
2.64x
INFY
5.14x
EPSINFY has the higher reading
DRREDDY
₹41.33
INFY
₹77.13
Book ValueContext only
DRREDDY
₹460.31
INFY
₹226.41
Dividend YieldINFY has the higher reading
DRREDDY
0.69%
INFY
4.23%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
INFY is the larger company
₹4.75 L Cr vs ₹1 L Cr
P/E Ratio
INFY has a lower P/E
15.84x vs 31.05x
P/B Ratio
DRREDDY has a lower P/B
2.64x vs 5.14x
EPS
INFY has higher earnings per share
₹77.13 vs ₹41.33
Dividend Yield
INFY has a higher dividend yield
4.23% vs 0.69%
Revenue Growth (TTM YoY)
INFY has faster revenue growth
6.6% vs -11.6%
EPS Growth (TTM YoY)
INFY has faster EPS growth
11.8% vs -86.2%
Qtr Sales Growth
INFY has stronger quarterly sales growth
13.4% vs -11.5%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricDRREDDYINFY
SectorHealthcareInformation Technology
IndustryPharmaceuticalsComputers - Software & Consulting

Price

MetricDRREDDYINFY
Live Price₹1,200₹1,176.1
Day Change-0.41%-1.23%
Volume23.67 L75.3 L
52-Week High₹1,414.9₹1,728
52-Week Low₹1,101₹982.4
Distance from 52W High-15.19%-31.94%

Valuation

MetricDRREDDYINFY
Market Cap₹1 L Cr₹4.75 L Cr
P/E Ratio31.05x15.84x
P/B Ratio2.64x5.14x
EPS₹41.33₹77.13
Book Value₹460.31₹226.41
Dividend Yield0.69%4.23%

Growth

MetricDRREDDYINFY
Revenue Growth (TTM YoY)-11.6%6.6%
EPS Growth (TTM YoY)-86.2%11.8%
Qtr Sales Growth-11.5%13.4%
Qtr Profit Growth-86.1%20.9%

Profitability & Leverage

MetricDRREDDYINFY
ROE11.2%31.9%
ROCE13%40%
Net Margin12.76%16.44%
Operating Margin19.2%23.7%
Debt to Equity0.2x0.1x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricDRREDDYINFY
Promoter Holding26.64% 0.01 pp13.82% 0.56 pp
FII Holding32.07% 1.01 pp27.09% 1.36 pp
DII Holding31.74% 1.02 pp42.96% 0.42 pp
Public Holding9.35% 0.02 pp15.89% 2.36 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Dr Reddys Laboratories Ltd and Infosys Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.